Insurance

Progressive Corp insider trading insights: executive RSU‑driven purchases, disciplined sales, and alignment with shareholder value for 2026.

Palomar Holdings’ CEO’s July 21 insider sale shows routine portfolio rebalancing, not a warning, and highlights how data‑driven underwriting, ESG rules and platformization shape specialty‑insurance and cross‑sector growth.

Insider buying at Erie Indemnity shows long‑term confidence in the insurer’s digital shift and stable DDC gains—a sign investors may want to watch for a rebound.

Erie Indemnity’s steady insider buying signals confidence in a solid P&C business and undervalued stock – a long‑term play for investors.

Palomar Holdings insider buy shows exec confidence; learn how strategic ESPP deals and robust risk‑management shape the insurer’s future.

CEO Jeffrey Radke’s July 17 insider sale of Accelerant Holdings shares shows routine wealth‑management moves, not panic—track its impact on investor sentiment and the firm’s AI‑driven underwriting strategy.

Insider CFO buys 161 shares at $9.76, boosting confidence in Kingsway Corp’s mortgage‑securitisation strategy and hinting at a potential upside after a year‑long slump.

Progressive CEO sells 6,043 shares under 10b5‑1 plan, showing disciplined liquidity while the company navigates earnings miss and stock slide.

CEO sells 80,000 Accelerant shares via Rule 10b5‑1 amid a 52 % YTD decline – a structured liquidity move that analysts say signals strategic shifts, not panic.

Executive buys at a discount reveal confidence in Willis Towers Watson’s risk‑management, cyber‑analytics, and climate‑disclosure strengths—key insights for investors navigating the insurance market.